RESUMO
In decapod crustaceans, lipids and the associated carotenoid pigments form an integral part of yolk to serve as nutrientsduring embryogenesis. This study reports on the analysis of different lipid classes and the major carotenoids in the ovary,hepatopancreas and hemolymph and their fluctuation during different phases of ovarian maturation in an anomuran crab, Emerita asiatica. Neutral lipids including triglycerides (TG) and free fatty acids (FFA) formed the bulk of ovarian lipids. Important fatty acids are Saturated fatty acids (SFA) 16:0 and 18:0, Monounsaturated fatty acids (MUFA) 16:1n7 and18:1n9, and Polyunsaturated fatty acids (PUFA) 20:5n3 and 22:6n3. While phospholipids increased during maturation, glycolipids decreased. Cholesterol level in ovary increased initially, but declined during later stages. Dominant pigments, ?-carotene and astaxanthin, steadily increased during ovarian maturation within the ovary, although canthaxanthin declineddrastically towards last stage. In hepatopancreas, however, TG and FFA showed gradual decrease during maturation. Palmitic acid, palmitoleic acid and eicosapentaenoic acid are the predominant fatty acids in hepatopancreas, showing asteady decline during ovarian maturation. Other lipid classes such as glycolipids also showed a decline in hepatopancreas. Both ?-carotene and astaxanthin in hepatopancreas declined from the first stage of ovarian development, suggestingtranslocation to ovary. The overall metabolic changes of lipids and carotenoids in hepatopancreas, hemolymph and ovary areindicative of their accumulation within developing eggs to provide metabolic energy and substrates for membrane formation, and to serve as precursors for pigment formation respectively, during embryogenesis.
RESUMO
Background@#Evaluate morbidities and “quality” of fiducial marker placement in primary liver tumours (hepatocellular carcinoma [HCC]) for CyberKnife. @*Materials and Methods@#Thirty-six HCC with portal vein thrombosis(PVT) were evaluated for “quality” of fiducial placement, placement time, pain score, complications, recovery time and factors influencing placement. @*Results@#One hundred eight fiducials were placed in 36 patients. Fiducial placement radiation oncologist score was “good” in 24(67%), “fair” in 4(11%), and “poor” in 3(8%) patients. Concordance with radiologist score in “poor”, “fair”, and “good” score was 2/2(100%), 4/5(80%), and 24/27(89%), respectively(p=0.001). Child-Pugh score(p=0.080), performance status(PS) (p=0.014) and accrued during “learning curve”(p=0.013) affected placement score. Mean placement time(p=0.055), recovery time(p=0.025) was longer and higher major complications(p=0.009) with poor PS. Liver segment involved(p=0.484) and the Barcelona Clinic Liver Cancer(BCLC) stage did not influence placement score. “Good” placement score was 30% in first cohort whereas 93% in last cohort(p=0.023). Time for placement was 42.2 and 14.3 minutes, respectively(p=0.069). Post-fiducial pain score 0–1 in 26 patients(72%) and pain score 3–4 was in 2(6%). Five patients (14%) admitted in “day-care”(2 mild pneumothorax, 3 pain). Mortality in 1 patient(3%) admitted for hemothorax. @*Conclusion@#Fiducial placement is safe and in experienced hands, “quality” of placement is “good” in majority. Major complications and admission after fiducial placement are rare. Complications, fiducial placement time, recovery time is more during the “learning curve”. Poor Child-Pugh score, extensive liver involvement, poor PS have higher probability of complications.
RESUMO
Background@#Evaluate morbidities and “quality” of fiducial marker placement in primary liver tumours (hepatocellular carcinoma [HCC]) for CyberKnife. @*Materials and Methods@#Thirty-six HCC with portal vein thrombosis(PVT) were evaluated for “quality” of fiducial placement, placement time, pain score, complications, recovery time and factors influencing placement. @*Results@#One hundred eight fiducials were placed in 36 patients. Fiducial placement radiation oncologist score was “good” in 24(67%), “fair” in 4(11%), and “poor” in 3(8%) patients. Concordance with radiologist score in “poor”, “fair”, and “good” score was 2/2(100%), 4/5(80%), and 24/27(89%), respectively(p=0.001). Child-Pugh score(p=0.080), performance status(PS) (p=0.014) and accrued during “learning curve”(p=0.013) affected placement score. Mean placement time(p=0.055), recovery time(p=0.025) was longer and higher major complications(p=0.009) with poor PS. Liver segment involved(p=0.484) and the Barcelona Clinic Liver Cancer(BCLC) stage did not influence placement score. “Good” placement score was 30% in first cohort whereas 93% in last cohort(p=0.023). Time for placement was 42.2 and 14.3 minutes, respectively(p=0.069). Post-fiducial pain score 0–1 in 26 patients(72%) and pain score 3–4 was in 2(6%). Five patients (14%) admitted in “day-care”(2 mild pneumothorax, 3 pain). Mortality in 1 patient(3%) admitted for hemothorax. @*Conclusion@#Fiducial placement is safe and in experienced hands, “quality” of placement is “good” in majority. Major complications and admission after fiducial placement are rare. Complications, fiducial placement time, recovery time is more during the “learning curve”. Poor Child-Pugh score, extensive liver involvement, poor PS have higher probability of complications.
RESUMO
<p><b>OBJECTIVE</b>The aim of the present study was to isolate the anti-MRSA (Methicillin Resistant Staphylococcus aureus) molecule from the Mangrove symbiont Streptomyces and its biomedical studies in Zebrafish embryos.</p><p><b>METHODS</b>MRSA was isolated from the pus samples of Colachal hospitals and confirmed by amplification of mecA gene. Anti-MRSA molecule producing strain was identified by 16s rRNA gene sequencing. Anti-MRSA compound production was optimized by Solid State Fermentation (SSF) and the purification of the active molecule was carried out by TLC and RP-HPLC. The inhibitory concentration and LC50 were calculated using Statistical software SPSS. The Biomedical studies including the cardiac assay and organ toxicity assessment were carried out in Zebrafish.</p><p><b>RESULTS</b>The bioactive anti-MRSA small molecule A2 was purified by TLC with Rf value of 0.37 with 1.389 retention time at RP-HPLC. The Inhibitory Concentration of the purified molecule A2 was 30 µg/mL but, the inhibitory concentration of the MRSA in the infected embryo was 32-34 µg/mL for TLC purified molecule A2 with LC50 mean value was 61.504 µg/mL. Zebrafish toxicity was assessed in 48-60 µg/mL by observing the physiological deformities and the heart beat rates (HBR) of embryos for anti MRSA molecule showed the mean of 41.33-41.67 HBR/15 seconds for 40 µg/mL and control was 42.33-42.67 for 15 seconds which significantly showed that the anti-MRSA molecule A2 did not affected the HBR.</p><p><b>CONCLUSIONS</b>Anti-MRSA molecule from Streptomyces sp PVRK-1 was isolated and biomedical studies in Zebrafish model assessed that the molecule was non toxic at the minimal inhibitory concentration of MRSA.</p>